Nexalis Therapeutics Limited (ASX:NX1)
0.0130
0.00 (0.00%)
At close: Jun 19, 2026
-67.50% (1Y)
| Market Cap | 3.29M -42.2% |
| Revenue (ttm) | 986.43K +145.5% |
| Net Income | -1.62M |
| EPS | -0.01 |
| Shares Out | 253.04M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 673,090 |
| Open | 0.0140 |
| Previous Close | 0.0130 |
| Day's Range | 0.0130 - 0.0140 |
| 52-Week Range | 0.0120 - 0.0480 |
| Beta | 0.15 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 21, 2026 |